Yu-li L. Su
Kaohsiung, KHQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 69 publications
Oncogenic PIK3CA mutation enhances tumor immunogenicity through the IRF1-NLRC5-MHC-I axis in urothelial carcinoma.
Journal: Journal for immunotherapy of cancer
Published: June 15, 2026
Optimizing third-line and beyond therapies for metastatic colorectal cancer in Taiwan: an evidence-based consensus.
Journal: Therapeutic advances in medical oncology
Published: February 02, 2026
Trifluridine/tipiracil and survival in mismatch repair-deficient metastatic colorectal cancer.
Journal: Therapeutic advances in medical oncology
Published: December 29, 2025
CD147 at the crossroads of glycoprotein networks, metabolic reprogramming, and metastatic progression.
Journal: Frontiers in immunology
Published: October 17, 2025
Early Prostate-Specific Antigen Dynamics as Predictors of Treatment Response and Survival Outcomes in Patients with Castration-Resistant Prostate Cancer and Bone Metastases Undergoing Radium-223 Therapy.
Journal: The world journal of men's health
Published: July 26, 2025
Efficacy and safety of first-line cetuximab therapy for older patients (aged ≥ 70 years) with RAS wild-type metastatic colorectal cancer: a nationwide real-world study.
Journal: American journal of cancer research
Published: June 04, 2025
Avelumab plus sacituzumab govitecan versus avelumab monotherapy as first-line maintenance treatment in patients with advanced urothelial carcinoma: JAVELIN Bladder Medley interim analysis.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 14, 2025
Multicenter, international, retrospective study of prognostic factors for Ra223.
Journal: Scientific reports
Published: November 08, 2024
Outcomes of upfront primary tumor resection in patients with synchronous RAS wild-type metastatic colorectal cancer.
Journal: American journal of cancer research
Published: October 07, 2024
Long-term outcome of radiation therapy for locoregional recurrence of upper tract urothelial carcinoma after nephroureterectomy.
Journal: BMC urology
Published: October 01, 2024
Continuing anti-EGFR monoclonal antibody after secondary resection significantly prolongs overall survival for patients with metastatic colorectal cancer who were responsive to first-line anti-EGFR monoclonal antibody plus chemotherapy doublet.
Journal: American journal of cancer research
Published: September 16, 2024
Impact of iron-deficiency anemia on short-term outcomes after resection of colorectal cancer liver metastasis: a US National (Nationwide) Inpatient Sample (NIS) analysis.
Journal: Annals of coloproctology
Published: September 03, 2024
Last Updated: 09/26/2026